Galmed Pharmaceuticals (GLMD) Cash from Operations (2013 - 2026)
Galmed Pharmaceuticals (GLMD) posted quarterly Cash from Operations of 2536000.0 for Q1 2026, down 117.31% year-over-year from 14651049.5 in Q1 2025, and down 192.45% quarter-over-quarter from 2743000.0 in Q4 2025.
Galmed Pharmaceuticals (GLMD) Cash from Operations (2013 - 2026) Analysis & Trends
Galmed Pharmaceuticals' Cash from Operations history runs 14 years deep, the most recent figure standing at 2536000.0 for Q1 2026.
- In Q1 2026, Cash from Operations fell 117.31% year-over-year to 2536000.0; the TTM figure through Mar 2026 stood at 2996000.0 (down 116.16% YoY), while the FY2025 annual figure was 1627000.0, up 20.6% from the prior year.
- Cash from Operations for Q1 2026 stood at 2536000.0, down from 2743000.0 in the prior quarter.
- The five-year high for Cash from Operations was 2743000.0 in Q4 2025, with the low at 11107000.0 in Q2 2022.
- The 5-year median for Cash from Operations is 1367000.0 (2023), against an average of 1814705.88.
- The sharpest annual moves came in 2023 and 2024: Cash from Operations sank 562.11% in 2023, then soared 314.14% in 2024.
- Galmed Pharmaceuticals' Cash from Operations stood at 4024000.0 in 2022, then surged by 77.68% to 898000.0 in 2023, then jumped by 314.14% to 1923000.0 in 2024, then surged by 42.64% to 2743000.0 in 2025, then tumbled by 192.45% to 2536000.0 in 2026.
- Business Quant data shows GLMD's Cash from Operations at 2536000.0 in Q1 2026, 2743000.0 in Q4 2025, and 1934000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 326.72 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -88.83 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 728.46 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 360.27 Mn |
| 10 | Galmed Pharmaceuticals | 2.39 Mn | -9.49 Mn | - | -2.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.54 Mn |
| Mar 31, 2026 | -2.54 Mn |
| Dec 31, 2025 | 2.74 Mn |
| Dec 31, 2025 | 2.74 Mn |
| Sep 30, 2025 | -1.93 Mn |
| Sep 30, 2025 | -1.93 Mn |
| Jun 30, 2025 | -1.27 Mn |
| Jun 30, 2025 | -1.27 Mn |
| Mar 31, 2025 | -1.17 Mn |
| Mar 31, 2025 | -1.17 Mn |
| Dec 31, 2024 | 1.92 Mn |
| Dec 31, 2024 | 1.92 Mn |
| Sep 30, 2024 | -1.13 Mn |
| Sep 30, 2024 | -1.13 Mn |
| Jun 30, 2024 | -1.02 Mn |
| Jun 30, 2024 | -1.02 Mn |
| Mar 31, 2024 | -1.83 Mn |
| Mar 31, 2024 | -1.83 Mn |
| Dec 31, 2023 | -898,000.00 |
| Dec 31, 2023 | -898,000.00 |